Loading…
Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo
17-Azolyl steroids were synthesized and evaluated as inhibitors of androgen synthesis in vitro and in vivo. Several of the novel compounds exhibit potent noncompetitive inhibition of human 17α-hydroxylase/C 17,20-lyase with IC 50 values ranging from 7 to 90 nM, and K i values from 1.2 to 41 nM. VN/8...
Saved in:
Published in: | The Journal of steroid biochemistry and molecular biology 1999-12, Vol.71 (3), p.145-152 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 17-Azolyl steroids were synthesized and evaluated as inhibitors of androgen synthesis in vitro and in vivo. Several of the novel compounds exhibit potent noncompetitive inhibition of human 17α-hydroxylase/C
17,20-lyase with IC
50 values ranging from 7 to 90 nM, and
K
i values from 1.2 to 41 nM.
VN/85-1 and
VN/108-1 were the most potent inhibitors against this enzyme with IC
50 value of 8 nM (
K
i of 1.2 nM) and 7 nM (
K
i of 1.9 nM), respectively.
VN/107-1,
VN/108-1 and
VN/109-1 also showed moderate inhibition of 5α-reductase in human prostatic microsomes. Normal adult male rats were treated with these novel 17-azolyl steroidal compounds at a dose level of 50 mg/kg, s.c., for 14 consecutive days, sacrificed 1–2 h after the last administered dose and blood, prostate and other tissues were collected. The organs were weighed and tissue concentrations of testosterone (T) and dihydrotestosterone (DHT) were measured. Tissue T levels were significantly (
p |
---|---|
ISSN: | 0960-0760 1879-1220 |
DOI: | 10.1016/S0960-0760(99)00129-6 |